chr5-36105150-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001007527.2(LMBRD2):c.1945A>T(p.Ile649Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001007527.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMBRD2 | NM_001007527.2 | c.1945A>T | p.Ile649Leu | missense_variant | 17/18 | ENST00000296603.5 | NP_001007528.1 | |
LMBRD2 | XM_011514162.3 | c.1945A>T | p.Ile649Leu | missense_variant | 17/18 | XP_011512464.1 | ||
LMBRD2 | XM_047417877.1 | c.1282A>T | p.Ile428Leu | missense_variant | 13/14 | XP_047273833.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250806Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135564
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460628Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 726618
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74290
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.1945A>T (p.I649L) alteration is located in exon 17 (coding exon 16) of the LMBRD2 gene. This alteration results from a A to T substitution at nucleotide position 1945, causing the isoleucine (I) at amino acid position 649 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at